Table 4 CQ Treatment failures by Day 28 (adjusted by genotyping), stratified by age group and study site
CQ | No. of treatment failure/Total of Patients (%) [95% CI] | |||
|---|---|---|---|---|
0.5 – 4 years | ≥ 5 years | All age | ||
Tropical | Maevatanana | 19/28 (67.9) [49.1–83.0] | 9/24 (37.5) [20.1–57.8] | 28/52 (53.8) [40.3–67.0] |
Miandrivazo | 10/16 (62.5) [37.6–83.2] | 16/50 (32.0) [20.2–45.8] | 26/66 (39.4) [28.2–51.5] | |
Highlands | Moramanga | 10/26 (38.5) [21.5–57.9] | 3/10 (30.0) [8.3–62.0] | 13/36 (36.1) [21.8–52.6] |
Tsiroanomandidy | 13/21 (61.9) [40.2–80.5] | 9/17 (52.9) [29.7–75.2] | 22/38 (57.9) [41.9–72.7] | |
Sub-desert | Ejeda | 14/20 (70.0) [47.7–86.8] | 18/30 (60.0) [41.9–76.2] | 32/50 (64.0) [50.1–76.4] |
Ihosy | 3/20 (15.0) [4.0–35.6] | 8/38 (21.1) [10.3–36.1] | 11/58 (19.0) [10.4–30.6] | |